Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02348255
Title NovoTTF-100A in Combination With Bevacizumab and Carmustine in Treating Patients With Glioblastoma Multiforme in First Relapse
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of California, Davis
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.